Europe Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

  • Pharmaceutical
  • Published Report
  • Apr 2018
  • Europe
  • 175 Pages
  • No of Tables: 15
  • No of Figures: 333

Europe Injectable Drug Delivery Market, Type (Injectable Drug Delivery Devices,Injectable Drug Delivery Formulation), Application (Hormonal Disorders, oncology, autoimmune diseases), Usage Pattern (Curative Care, Other Usage Pattern ), Mode Of Administration, End User (Hospitals And Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical And Biotechnological Companies, Other End Users), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy),By Country (Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherland and rest of Europe) – Industry Trends and Forecast to 2025

The Europe Injectable Drug Delivery Market is expected to reach USD 369,668.94 million by 2025, from USD 122,906.09 million in 2017 growing at a CAGR of 12.8% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.

Market Segmentation: Europe Injectable Drug Delivery Market

  • The Europe injectable drug delivery market is segmented on of type, portability, type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
  • The Europe injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 83.4% market share in 2018, growing at a CAGR of 12.6% and will cross USD 304,070.7 million by 2025.
  • On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anaemia      , osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 48.3% market share in 2018, growing at a CAGR of 12.1% and will cross USD 169,847.2 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 14.1% in the forecast period, and is expected to reach USD 84,577.4 million in 2025 from USD 25,259.9 million in 2017.
  •  On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 94.9% market share in 2018, growing at the highest CAGR of 12.8% and will cross USD 351,807.22 million by 2025.
  • On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
  • The Injectable drug delivery market is dominated by skin with 48.1% market share in 2018, growing with the highest CAGR of 13.0% and will cross USD 179,882.7 million by 2025.
  • On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 61.8% market share in 2018, growing at a CAGR of 12.9% and will cross USD 230,052.8 million by 2025. However, home healthcare settings companies segment is expected to grow at the highest CAGR of 14.5% in the forecast period, and is expected to reach USD 79,428.6 million in 2025 from USD 22,963.21 million in 2017
  • On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 71.0% market share in 2018, growing at a CAGR of 13.0% and will cross USD 266,909.5 million by 2025.

 Key Drivers: Europe Injectable Drug Delivery Market

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market

Key Points: Europe Injectable Drug Delivery Market

Europe injectable drug delivery market is dominated by Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak, among other players

  • Conventional injectable devices is expected to dominate the Europe injectable drug delivery market With market share of 80.9%
  • The injectable drug delivery market in the Europe region is leading in Germany, France, Norway, Italy, Italy, U.K. Germany is growing with the highest CAGR of 15.6%

SKU-

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE